MAPT and Alzheimer disease: Abnormal levels of amyloid-β and tau may initiate the production of the proinflammatory cytokines and chemokines that trigger the neuronal synaptic dysfunction and neuroinflammation associated with AD.74,75 SHP2 was shown to act downstream of cKit, which controlled the degradation of amyloid-β protein precursor.